Global Pharma Healthcare Private Limited

5 FDA enforcement actions

5 Total Recalls

3 Class I

2 Class II

0 Class III

Firm Details

Product Types: drug
States: N/A

All Recalls

Class I: Dangerous 02/24/2023 drug

Non-Sterility: FDA analysis found unopened tubes to be contaminated with bacteria.
Class I: Dangerous 01/30/2023 drug

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class I: Dangerous 01/30/2023 drug

Non-Sterility: FDA analysis found unopened products to have bacterial contamination.
Class II: Risk 01/30/2023 drug

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Class II: Risk 01/30/2023 drug

CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.